VYS 1.32% 38.5¢ vysarn limited

strategic review, page-17

  1. 415 Posts.
    bloody hell this thing is giving me ulcers. hopefully in 6 weeks we'll know exactly where we stand and can either lick our wounds or move onto the US in confidence.

    personally i'm not too fussed about the profitability of geelong. always just saw it as just a lab and felt so long as it proved that the tech works then it could run at breakeven or even a small loss for all i cared. US and then worldwide expansion is the big picture.

    hopefully then this review is primarily geelong centric and we can move fwd with financing the US even if it does mean a cap raising.

    if the review, however, throws doubt on the tech well then its game over and its wrist slashing time.
 
watchlist Created with Sketch. Add VYS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.